ESO–EANS Rewrites the Rulebook on Spontaneous ICH: First Update Since 2014
The European Stroke Organization (ESO) has recently shared an insightful post on X:
”The new ESO–EANS guideline on intracerebral haemorrhage outlines best practice for acute care, surgery, and blood pressure control.”
To access the guideline, read the full article here.
Thorsten Steiner et al. shade light on the management of intracerebral haemorrhage in a newly published ”European Stroke Organisation (ESO) and European Association of Neurosurgical Societies (EANS) guideline on stroke due to spontaneous intracerebral haemorrhage” in the SAGE Journals.
The European Stroke Organisation (ESO) and European Association of Neurosurgical Societies (EANS) have updated their guidelines on spontaneous ICH for the first time since 2014.
Despite reviewing over 115,000 articles and including 208 studies, only a handful of strong recommendations emerged.
These include treating ICH patients in organised stroke units and lowering blood pressure to prevent recurrence.
- Strong evidence supports stroke unit care and blood pressure control for secondary prevention, while weak evidence backs prediction scores for macrovascular causes of ICH.
- Strong evidence discourages anti-inflammatory use outside trials, while weak evidence cautions against routine use of rFVIIa, platelet transfusions, early treatment restrictions, and isolated temperature or glucose control.
These and more findings highlight the ongoing need for high-quality trials embedded in clinical care.
Read the latest updates on thrombosis and bleeding disorders in Hemostasis Today.
-
Aug 26, 2025, 10:02Women’s Equality Day: HFA Recognizes Women with Bleeding Disorders
-
Aug 26, 2025, 09:59Rare Disease Advisor – RBC Rheology Alterations in Hemophilia with Arthropathy
-
Aug 26, 2025, 09:57HFA Supports Future Planning for People with Bleeding Disorders
-
Aug 26, 2025, 09:56Phillip Taboada: TXA Shows No Added Benefit in Aquablation
-
Aug 26, 2025, 09:50A Global Collaboration: PERT Consortium Expands Reach in PE Care
-
Aug 26, 2025, 09:54TSUBASA Study: Emicizumab Improves Daily Life and Motivation in Hemophilia A Patients
-
Aug 26, 2025, 09:38Advancing CAT Care: New Insights on Extended Anticoagulation from Gerotziafas and Tafur
-
Aug 26, 2025, 09:35Alexander Mazein: Innovative Insights into Cytokine Release Syndrome via a Novel Explorable Model for Biotherapeutics and Cellular Therapies
-
Aug 25, 2025, 10:40Maria Filomena Ruberto on The Hypercoagulable State
-
Aug 25, 2025, 09:19Parham Dastjerdi – Clonal Hematopoiesis and VTE Risk
-
Aug 18, 2025, 23:56Dr. Arun V. J Invites You to His Lecture on ‘AI and Data Sciences in Transfusion Medicine’ at the AI in Healthcare Conclave. Register now!
-
Aug 18, 2025, 23:50Safe and Efficient Thrombectomy with Artix System: Clinical Insights from Neil Desai and Colleagues
-
Aug 16, 2025, 14:42Mark Crowther Honors Davide Matino for Leading Promising Hemophilia Trial at McMaster University
-
Aug 14, 2025, 10:28Impressive 95% Clot Removal in a VTE Case: Symphony16F and Symphony24F Catheters
-
Jul 28, 2025, 14:55HORIBA Decoding High Efficiency in Hematology Lab: Free Online Workshop
-
Aug 26, 2025, 09:42David McIntosh Highlights Global Blood Shortages and Fresh vs Stored RBCs
-
Aug 23, 2025, 07:48Protecting Heart and Brain Health: Stroke Prevention in Women with Bleeding Disorders: NBDF
-
Aug 21, 2025, 15:08Global Variations in Blood Collection: What Explains the Differences?
-
Aug 20, 2025, 13:33Askat's Life with Hemophilia A after Access to Prophylactic Treatment Through the WFH Humanitarian Aid Program
-
Aug 19, 2025, 17:22Louise Bannon Encourages You to Support World Thrombosis Day!